Lungu, M.; Oprea, V.D.; Apostol, L.L.; Elkan, E.M.; Ionescu, A.M.; Tudor, A.; Zaharia, L.A.
Levodopa–Carbidopa–Entacapone Intestinal Gel for Advanced Parkinson’s Disease—Results from a Monocentric Study Evaluating Both Motor and Non-Motor Manifestations. Biomedicines 2025, 13, 2191.
https://doi.org/10.3390/biomedicines13092191
AMA Style
Lungu M, Oprea VD, Apostol LL, Elkan EM, Ionescu AM, Tudor A, Zaharia LA.
Levodopa–Carbidopa–Entacapone Intestinal Gel for Advanced Parkinson’s Disease—Results from a Monocentric Study Evaluating Both Motor and Non-Motor Manifestations. Biomedicines. 2025; 13(9):2191.
https://doi.org/10.3390/biomedicines13092191
Chicago/Turabian Style
Lungu, Mihaiela, Violeta Diana Oprea, Luminița Lăcrămioara Apostol, Eva Maria Elkan, Ana Maria Ionescu, Anca Tudor, and Lucian Andrei Zaharia.
2025. "Levodopa–Carbidopa–Entacapone Intestinal Gel for Advanced Parkinson’s Disease—Results from a Monocentric Study Evaluating Both Motor and Non-Motor Manifestations" Biomedicines 13, no. 9: 2191.
https://doi.org/10.3390/biomedicines13092191
APA Style
Lungu, M., Oprea, V. D., Apostol, L. L., Elkan, E. M., Ionescu, A. M., Tudor, A., & Zaharia, L. A.
(2025). Levodopa–Carbidopa–Entacapone Intestinal Gel for Advanced Parkinson’s Disease—Results from a Monocentric Study Evaluating Both Motor and Non-Motor Manifestations. Biomedicines, 13(9), 2191.
https://doi.org/10.3390/biomedicines13092191
